1.20
Synlogic Inc stock is traded at $1.20, with a volume of 6,078.
It is up +3.36% in the last 24 hours and up +19.42% over the past month.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.19
Open:
$1.24
24h Volume:
6,078
Relative Volume:
0.13
Market Cap:
$14.04M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.1116
EPS:
-10.7522
Net Cash Flow:
$-51.83M
1W Performance:
+8.85%
1M Performance:
+19.42%
6M Performance:
+4.24%
1Y Performance:
-13.38%
Synlogic Inc Stock (SYBX) Company Profile
Name
Synlogic Inc
Sector
Industry
Phone
617-659-2802
Address
PO BOX 30, WINCHESTER, MA
Compare SYBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYBX
Synlogic Inc
|
1.20 | 13.92M | 3.37M | -57.28M | -51.83M | -10.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.21 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.83 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
405.25 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
802.32 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.76 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-21-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-30-19 | Initiated | Jefferies | Buy |
| Dec-13-18 | Initiated | Chardan Capital Markets | Buy |
| Mar-19-18 | Initiated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Piper Jaffray | Overweight |
View All
Synlogic Inc Stock (SYBX) Latest News
Synlogic Inc Stock Analysis and ForecastTechnical Pattern Recognition & Capitalize On Fast Trends - earlytimes.in
Aug PreEarnings: How strong is Synlogic Inc. stock balance sheetWatch List & Real-Time Buy Signal Notifications - moha.gov.vn
Price Action: Is Synlogic Inc stock gaining market share2025 Breakouts & Breakdowns & High Conviction Investment Ideas - moha.gov.vn
MSN Money - MSN
Can Synlogic Inc. stock reach $100 price targetJuly 2025 Review & Stepwise Trade Signal Guides - Улправда
Aug Shorts: Can Synlogic Inc stock reach 100 price targetQuarterly Profit Report & Community Consensus Picks - moha.gov.vn
Is Synlogic Inc. stock vulnerable to regulatory risksEarnings Recap Report & Precise Trade Entry Recommendations - Улправда
Will Synlogic Inc. stock gain from government policiesMarket Movers & Low Drawdown Investment Ideas - Улправда
Will Synlogic Inc. stock benefit from infrastructure spendingJuly 2025 WrapUp & High Accuracy Swing Trade Signals - ulpravda.ru
Can Synlogic Inc. stock resist market sell offsPortfolio Value Report & Safe Investment Capital Preservation Plans - Улправда
Why Synlogic Inc. stock is rated strong buyQuarterly Investment Review & AI Powered Trade Plan Recommendations - Улправда
Will Synlogic Inc. stock maintain dividend yieldJuly 2025 Closing Moves & Technical Buy Zone Confirmations - Улправда
Synlogic Holds Annual Meeting, Elects Directors - The Globe and Mail
Synlogic shareholders approve new equity plan and reelect directors at annual meeting - Investing.com Nigeria
Synlogic shareholders approve new equity plan and reelect directors at annual meeting By Investing.com - Investing.com South Africa
Synlogic (NASDAQ: SYBX) 2025 meeting backs equity plan, directors, auditor - Stock Titan
Synlogic (SYBX) Stock Analysis Report | Financials & Insights - Benzinga
Get in on Synlogic Inc’s (SYBX) buy-in window today! - Setenews
Will Synlogic Inc. stock benefit from AI adoptionQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
How supply chain issues affect Synlogic Inc. stock2025 Risk Factors & Safe Capital Allocation Plans - Newser
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Can Synlogic Inc. stock maintain operating margins2025 Short Interest & High Return Trade Guides - Newser
Nasdaq notifies Synlogic of potential delisting over public shell status By Investing.com - Investing.com Australia
Synlogic Challenges Nasdaq Delisting Notice - MSN
Nasdaq notifies Synlogic of potential delisting over public shell status - Investing.com India
Why FWRG stock attracts high net worth investorsBuy Signal & High Accuracy Trade Signal Alerts - moha.gov.vn
Synlogic receives letter from Nasdaq listing qualifications department on Nov 21SEC filing - marketscreener.com
How Synlogic Inc. stock performs in weak economyJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
Is Synlogic Inc. stock a smart buy before Fed meetingEntry Point & Risk Managed Investment Signals - newser.com
Can Synlogic Inc. stock maintain growth trajectory2025 Sector Review & Weekly High Conviction Ideas - newser.com
Will Synlogic Inc. stock sustain high P E ratiosJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
What Wall Street predicts for Synlogic Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com
Is Synlogic Inc. stock supported by strong cash flowsEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
Can Synlogic Inc. stock sustain revenue growthRisk Management & Weekly Top Performers Watchlists - newser.com
Synlogic Inc Stock (SYBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Synlogic Inc Stock (SYBX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dooley Mary Beth | See Remarks below |
Apr 02 '25 |
Sale |
1.20 |
144 |
173 |
12,901 |
| Dooley Mary Beth | See Remarks below |
Feb 03 '25 |
Sale |
1.33 |
2,107 |
2,802 |
13,045 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):